Surgical resection of pulmonary metastases from colorectal cancer: 11 years of experiences
- PMID: 28394911
- PMCID: PMC5386242
- DOI: 10.1371/journal.pone.0175284
Surgical resection of pulmonary metastases from colorectal cancer: 11 years of experiences
Abstract
Objective: To analyze the benefits and prognostic factors after surgical resection of pulmonary metastases from colorectal cancer (CRC).
Methods: From Jan. 2004 to Jan. 2015, continuous 88 cases diagnosed with pulmonary metastases from CRC, including 15 cases of synchronous metastases and 73 metachronous metastases, were analyzed in the retrospective study.
Results: All of these 88 cases underwent curative pulmonary resection including 8 cases of simultaneous surgery. The one-year, three-year and five-year survival of the 88 cases were 93.4%, 60.2% and 35.7%, respectively. 63 patients just have one metastasis, and 25 patients have more than one metastasis. Additionally, the one-year, three-year and five-year survival was 98.1%, 70.2% and 40.3% respectively in one metastasis group, while 80.1%, 37.9% and 22.5% respectively in more than one metastasis group (p = 0.003). DFS of 37 metachronous metastases were equal or greater than 18 months, and DFS of 36 metachronous metastases were less than 18 months. The one-year, three-year and five-year survival was 97.8%, 77.9% and 41.4% respectively in the DFS≥18 month group, while 88.2%, 44.6% and 28.1% respectively in the DFS<18 month group (p = 0.01).
Conclusion: Surgical resection of pulmonary metastases from colorectal cancer can improve survival rate in selected patients. It seems that the number of metastases is an independence prognostic factor in surgical treatment. Furthermore, longer DFI implies longer survival for resectable CRC pulmonary metastases.
Conflict of interest statement
Figures




Similar articles
-
Curative Resection for Metachronous Pulmonary Metastases from Colorectal Cancer: Analysis of Survival Rates and Prognostic Factors.Cancer Res Treat. 2017 Jan;49(1):104-115. doi: 10.4143/crt.2015.367. Epub 2016 May 9. Cancer Res Treat. 2017. PMID: 27188203 Free PMC article.
-
Prognostic value of p53 for colorectal cancer after surgical resection of pulmonary metastases.World J Surg Oncol. 2016 Dec 21;14(1):308. doi: 10.1186/s12957-016-1049-4. World J Surg Oncol. 2016. PMID: 28003030 Free PMC article.
-
Clinical significance of systemic chemotherapy after curative resection of metachronous pulmonary metastases from colorectal cancer.Cancer Chemother Pharmacol. 2017 Jul;80(1):187-193. doi: 10.1007/s00280-017-3348-z. Epub 2017 Jun 8. Cancer Chemother Pharmacol. 2017. PMID: 28597039
-
Benefits of surgery for patients with pulmonary metastases from colorectal carcinoma.Ann Thorac Surg. 2004 Jul;78(1):238-44. doi: 10.1016/j.athoracsur.2004.02.017. Ann Thorac Surg. 2004. PMID: 15223436 Review.
-
[Prognostic factors associated with resectable pulmonary metastases from colorectal cancer].Arch Bronconeumol. 2007 Jun;43(6):309-16. Arch Bronconeumol. 2007. PMID: 17583640 Review. Spanish.
Cited by
-
Case Report: Long-term survival of a patient with advanced rectal cancer and multiple pelvic recurrences after seven surgeries.Front Oncol. 2023 May 15;13:1169616. doi: 10.3389/fonc.2023.1169616. eCollection 2023. Front Oncol. 2023. PMID: 37256170 Free PMC article.
-
Pulmonary Metastasectomy for Colorectal Cancer: Evidence and Outcomes-A Narrative Review.J Clin Med. 2025 Jun 12;14(12):4172. doi: 10.3390/jcm14124172. J Clin Med. 2025. PMID: 40565918 Free PMC article. Review.
-
Decoding colorectal cancer lung metastasis: a global research odyssey.Front Oncol. 2025 Jul 24;15:1587422. doi: 10.3389/fonc.2025.1587422. eCollection 2025. Front Oncol. 2025. PMID: 40777130 Free PMC article.
-
Clinicopathological features and prognosis of intestinal hepatoid adenocarcinoma: evaluation of a pooled case series.Oncotarget. 2017 Dec 21;9(2):2715-2725. doi: 10.18632/oncotarget.23595. eCollection 2018 Jan 5. Oncotarget. 2017. PMID: 29416804 Free PMC article.
-
The importance of synchronicity in the management of colorectal peritoneal metastases with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.World J Surg Oncol. 2020 Jan 13;18(1):10. doi: 10.1186/s12957-020-1784-4. World J Surg Oncol. 2020. PMID: 31931817 Free PMC article.
References
-
- Weiss L, Grundmann E, Torhorst J, Hartveit F, Moberg I, Eder M, et al. Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies. The Journal of pathology. 1986;150(3):195–203. Epub 1986/11/01. doi: 10.1002/path.1711500308 - DOI - PubMed
-
- Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. The New England journal of medicine. 2005;352(5):476–87. Epub 2005/02/04. doi: 10.1056/NEJMra040958 - DOI - PubMed
-
- Rotolo N, De Monte L, Imperatori A, Dominioni L. Pulmonary resections of single metastases from colorectal cancer. Surgical oncology. 2007;16 Suppl 1:S141–4. Epub 2007/11/27. - PubMed
-
- Koodziejski L, Goralczyk J, Dyczek S, Duda K, Nabiaek T. The role of surgery in lung metastases. European journal of surgical oncology: the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 1999;25(4):410–7. Epub 1999/07/27. - PubMed
-
- Iizasa T, Suzuki M, Yoshida S, Motohashi S, Yasufuku K, Iyoda A, et al. Prediction of prognosis and surgical indications for pulmonary metastasectomy from colorectal cancer. The Annals of thoracic surgery. 2006;82(1):254–60. Epub 2006/06/27. doi: 10.1016/j.athoracsur.2006.02.027 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical